This year we are celebrating 25 years of smarter studies, global impact, and better health. '25 at 25' is a series of articles highlighting 25 of our major achievements.
Latest News
'25 at 25': Individual participant data (IPD) meta-analysis
The latest instalment of our ’25 at 25’ series explores how the Unit champions the use of individual participant data in meta-analyses, and how these studies have influenced the treatment of patients across a broad range…
15 Apr
Prostate cancer cases expected to double worldwide between 2020 and 2040, new analysis suggests
Researchers from the MRC Clinical Trials Unit at UCL have contributed to the new Lancet Commission on prostate cancer.
05 Apr
New animation clears up GDPR for research participants
We have produced a new animated video to help children and young people understand GDPR when they are being asked to take part in a clinical trial.
25 Mar
New classification of tuberculosis to support efforts to eliminate the disease
For World TB Day, a new way to classify tuberculosis (TB) that aims to improve focus on the early stages of the disease was presented by an international team involving researchers from the MRC Clinical Trials Unit at UC…
24 Mar
Research Themes
Cancer
Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types
Infections
Major international clinical trials answering questions of global public health significance
Neurodegenerative diseases
New generation of innovative multi-arm multi-stage trials to identify and test new therapeutic treatments in neurodegenerative diseases (NDD)
Methodology
Development of methods with direct impact on the design, conduct and analysis of studies
Other Research & Policy
This section will capture projects outside the current QQR themes